Addressing the world’s most pressing healthcare challenges
Addressing the world’s most pressing healthcare challenges
Johnson & Johnson MedTech is developing smarter, less invasive, more personalized treatments to tackle the most pervasive and complex diseases for people around the world.
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025